Author(s): Marcin Dzienis, MD1; Juan Cundom, MD2; Christian Sebastian Fuentes, MD3; Anna Spreafico, MD4; Melanie Nordlinger, MD5; Andrea Viviana Pastor, MD6; Erin Alesi, MD7; Anterpreet Neki, MD8; Andrea S. Fung, MD, PhD9; Iane Pinto Figueiredo Lima, MD10; Peter Oppelt, MD11; Geraldo Felicio da Cunha Junior, PhD12; Barbara Burtness, MD13; Fabio Andre Franke, MD14; Jennifer E. Tseng, MD15; Abhishek Joshi, MD16; Joy McCarthy, MD17; Ramona Swaby, MD18; Yulia Sidi, PhD18; Burak Gumuscu, MD, PhD18; Niroshini Naicker, MD19; Gilberto de Castro Jr, MD, PhD20
Author Affiliations
1Cancer Department, Gold Coast University Hospital, Southport, QLD, Australia; 2Department of Oncology, IDIM Instituto de Diagnóstico e Investigaciones Metabólicas, Buenos Aires, Argentina; 3Department of Oncology, Fundación Respirar, Buenos Aires, Argentina; 4Division of Medical Oncology and Hematology, Princess Margaret Cancer Center, Toronto, ON, Canada; 5Department of Medical Oncology, Sidney Kimmel Cancer Center at Jefferson-Abington Hospital, Philadelphia, PA; 6Department of Oncology, Hospital Provincial del Centenario, Rosario, Argentina; 7Department of Hematology/Oncology and Palliative Medicine, VCU Massey Cancer Center, Richmond, VA; 8Department of Hematology/Oncology, UC Davis Medical Center, Sacramento, CA; 9Department of Oncology, Cancer Centre of Southeastern Ontario at Kingston General Hospital, Kingston, ON, Canada; 10Department of Oncology, Centro Regional Integrado de Oncologia, Fortaleza, Brazil; 11Department of Oncology, Washington University School of Medicine, St Louis, MO; 12Department of Oncology, CETUS Oncologia, Belo Horizonte, Brazil; 13Yale University School of Medicine and Yale Cancer Center, New Haven, CT; 14Department of Oncology, Oncosite Centro de Pesquisa Clínica em Oncologia, Ijuí, Brazil; 15Department of Hematology and Oncology, Orlando Health Cancer Institute, Orlando, FL; 16Department of Medical Oncology, The Townsville University Hospital, Douglas, QLD, Australia; 17Dr. H. Bliss Murphy Cancer Centre, St John’s, NL, Canada; 18Merck & Co, Inc, Rahway, NJ; 19Oncology European Clinical Development, MSD (UK) Limited, London, United Kingdom; 20Clinical Oncology, Instituto do Câncer do Estado de São Paulo—ICESP, São Paulo, Brazil